SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QuestCor QSC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john e vanden biesen who wrote (17)1/10/1997 2:22:00 AM
From: Larry Liebman   of 120
 
Cypros released data from the first of a series of Phase 11 trials...Company reported "significant" results from closed-head-injury trial, stating they would file for Phase 111 trials ASAP...CYPR is trading around $5 with some 12 million shares outstanding- a market cap of $60 with products addressing large markets...Risk/reward looks quite good...Check out site at www.cypros.com....NeuroInvestment Newsletter is recommending the stock...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News